Secondary metabolites of fungi from marine habitats.
By M. Rateb, R. Ebel. Natural product reports (Print), 2011
601 citations recorded by the source corpus.
Subfields: Biotechnology, Pharmacology
View Paper: https://www.semanticscholar.org/paper/ea041270f93236ca79c274bd9261cd77bfec9a8b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biotechnology
In Pharmacology
Citations in the corpus
- Bioactive secondary metabolites from endophytes and associated marine derived fungi (2011, neutral): “…fungi associated with marine organisms, mainly with invertebrates such as sponges or with marine algae, were found to represent a vast untapped reservoir of metabolic diversity and have attracted growing attention in recent years (Bugni and Ireland 2004; Paz et al. 2010; Rateb and Ebel 2011).”
- The seaweed holobiont: understanding seaweed-bacteria interactions. (2013, background): “Marine epiphytic and endophytic fungi are also a source of natural defensive compounds that can be exploited as novel therapeutics (Rateb & Ebel, 2011), which could suggest a positive or protective role for fungi within the holobiont.”
- Aspernolides F and G, new butyrolactones from the endophytic fungus Aspergillus terreus (2015, background): “…fungi and their host plants is still poorly investigated, highly frequent isolation of endophytic fungi from plants has contributed a number of secondary metabolites with diverse structures and interesting biological activities (Rateb and Ebel, 2011; Zhang et al., 2006; * Corresponding author.”
- NATURAL PRODUCTS: A CONTINUING SOURCE OF NOVEL DRUG LEADS (2013, background): “Recent work, however, suggests that marine organisms, and perhaps a group of organisms that have not had very much published on them until recently, the marine-sourced fungi [252], will play an increasingly important role in the future, especially given the impressive advances in the power of organi”